glp 1 side effects after stopping Struggling with GLP-1 therapy effects? You're not alone. This Clinician Guide: Managing Common GLP-1 Receptor Agonist Side provides practical tips on recognizing, preventing and managing gastrointestinal and nutritional side effects GLP-1 Medications: Everything You Need

The "safer" option depends on the individual patient profile and treatment priorities

If youre unsure of how much to take, talk with your doctor about it

European Journal of Neuroscience

Here are some examples of GLP-1 agonists: Dulaglutide (marketed as Trulicity) Exenatide (marketed as Byetta and Bydureon) Liraglutide (marketed as Victoza) Lixisenatide (marketed as Adlyxin) Semaglutide (marketed as Ozempic and Rybelsus) Glucagon-like Peptide-1 (GLP-1) Agonists Market Analysis: The Glucagon-like Peptide-1 (GLP-1) Agonists Market size is estimated at USD 11.87 billion in 2023, and is expected to reach USD 12.55 billion by 2028, growing at a CAGR of 1.12% during the forecast period (2023-2028)

Branded Saxenda sales fell to roughly $300 million in the first half of 2025 as newer GLP-1 therapies, including semaglutide and tirzepatide, gained market share

Keep reading for an overview of Ros services, pricing, and how it works